FAQ > Glossary of Terms > F Series > FDA Form 483

A Series , B Series , C Series , D Series , E Series , F Series , G Series , H Series , I Series , K Series , L Series , M Series , N Series , O Series , P Series , Q Series , R Series , S Series , T Series , U Series , V Series , W Series , X Series , Y Series , Z Series

Face Velocity, Facility Flexibility, Facility User, Factor VIII(Hemophilia Factor), Factor IX(Hemophilia Factor), FDA Form 483, Fed Batch Fermentation, Federal Standard 209E, Feedback Loop, Feedwater, Fermentation, Fermenter, Fetal Calf Serum, Fever, Fibrin, Fibrinogen, Filtration, Fill and Finish(Parentral Drugs), Final Bulk Product, Finished Product, Firmware, FISH(Fluorescent In Situ Hybridization), Fissile Material, Flaggelae, Flammable Liquid, Flammable Solid, Flaws, Floc, Flocculation, Flow Cytometry, Flow Decay, Flow Restrictor, Fluid Service(Piping), Fluidized Bed, Fluorescein, Fluorinated Plastics, Flux Removers, Fomaldehyde, Forward Flow Test, Fouling, Fume Hoods, Functional Gene Tests, Functionality, Fungi, Fusion, Fusion Welding

Learn About Deadly Cancer Mesothelioma due to Asbestos Exposure, it can affect any one in the world

FDA Form 483
The official form of notification prepared at the conclusion of an inspection (without review by FDA management) listing observations of perceived violations of Good Manufacturing Practices that may constitute violations of law in the opinion of an inspector. Originally intended to inform companies of possible product adulteration, they must be replied to satisfactorily and/or corrective action taken in order to alleviate any offensive notification and avoid action from the FDA (i.e., plant shut-down). Accessible through the Freedom of Information Act to competitors, potential customers, and the media; 483s can lead to withholding of product approvals, may come into play in due diligence phases of acquisitions and mergers, and can potentially cost companies money